🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans

Matthew Keller

Stock Analyst at H.C. Wainwright

(0.07)
# 4,921
Out of 5,189 analysts
113
Total ratings
11.1%
Success rate
-39.2%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Matthew Keller

Kyntra Bio
Nov 17, 2026
Reiterated: Buy
Price Target: $43 → $18
Current: $1.56
Upside: +1,053.85%
Lakewood-Amedex Biotherapeutics
Nov 17, 2026
Reiterated: Buy
Price Target: $3
Current: $0.2449
Upside: +1,124.99%
Galectin Therapeutics
Nov 16, 2026
Reiterated: Buy
Price Target: $11
Current: $2.69
Upside: +308.92%
Phio Pharmaceuticals
Nov 16, 2026
Reiterated: Buy
Price Target: $14
Current: $0.656
Upside: +2,034.15%
Acurx Pharmaceuticals
Nov 13, 2026
Rated: Buy
Price Target: $31 → $11
Current: $1.04
Upside: +957.69%
MiNK Therapeutics
Nov 9, 2026
Reiterated: Buy
Price Target: $38
Current: $8.02
Upside: +373.82%
Gyre Therapeutics
Nov 6, 2026
Reiterated: Buy
Price Target: $18
Current: $4.21
Upside: +327.55%
Seres Therapeutics
Nov 4, 2026
Reiterated: Buy
Price Target: $12
Current: $1.24
Upside: +867.74%
InflaRx
Nov 3, 2026
Reiterated: Buy
Price Target: $8
Current: $1.04
Upside: +669.23%
60 Degrees Pharmaceuticals
Aug 18, 2026
Reiterated: Hold
Price Target: n/a
Current: $0.4682
Upside: -
Reiterated: Buy
Price Target: $10
Current: $1.12
Upside: +792.86%
Downgraded: Hold
Price Target: n/a
Current: $0.000001
Upside: -
Downgraded: Hold
Price Target: n/a
Current: $7.88
Upside: n/a